LHDX News and Press, Lucira Health Inc. From 01/20/23

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s the final day of trading this week and we’re checking in on the biggest pre-market stock movers for Friday morning! Our pre-market stock movers are filled to the brim...

In a regulatory filing , Lucira Health ( NASDAQ: LHDX ) announced that, effective January 10, 2023, the board appointed Richard Narido to serve as CFO. Narido has been serving as the company's interim CFO as well as principal financial officer and principal accounting officer since ...

SESAME PARTNERS WITH LUCIRA HEALTH AS OFFICIAL TELEHEALTH PROVIDER OF LAB-QUALITY TEST-TO-TREAT PROGRAM PR Newswire New partnership enables a free Sesame telehealth consultation with purchase of a Lucira at-home COVID-19 test, providing a full test-to-treat experience from the...

For $98 CAD Canadians will receive a free telehealth appointment included with purchase of a test Lucira Connect provides lab-quality at-home test-users a telehealth visit at no additional cost, enabling Test-to-Treatment within hours for only the cost of the test, excluding prescription ...

4 Mistakes Penny Stocks Traders Should Avoid This Year Trading penny stocks can be a risky but potentially rewarding venture, and it’s important for traders to be aware of common mistakes that can cost them money. Here are some of the biggest mistakes that traders should avoid when it ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the biggest upside movers in today’s upside-down market is medical technology company Lucira Health  (NASDAQ: LHDX ). This little-known maker of PCR tests for various infectious diseases is on a tear, with...

Cheap Stocks On Robinhood Moving On Tuesday Whether you call them cheap stocks, penny stocks, or lotto tickets, most day traders hunting for new opportunities typically include stocks under $5 on their list. Why? One of the biggest reasons is regarding how volatile low-priced stocks can be ...

Lucira Health ( NASDAQ: LHDX ) said it submitted an emergency use authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for OTC use of its at-home molecular COVID-19 & Flu test. Lucira noted that its test for COVID & Flu was granted EUA for po...

EMERYVILLE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health" or "Lucira"), a medical technology company, announced that it submitted an Emergency Use Authorization application to the FDA for OTC use of its simple, at-home molecular COVID-19 & Flu t...

Lucira COVID-19 & Flu Test is the first and only combination over-the-counter (OTC) self-test with fast, molecular lab-quality results enabling mass testing of symptomatic residents, staff and visitors amid the aggressive COVID-19 and flu season in Canada. Lucira’s 99% accurate, di...